Davis's Drug Guide
Reclipsen
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Reclipsen." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. www.drugguide.com/ddo/view/Davis-Drug-Guide/61501/all/Reclipsen.
Vallerand AHA, Sanoski CAC, . Reclipsen. Davis's Drug Guide. F.A. Davis Company; 2025. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/61501/all/Reclipsen. Accessed September 17, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). Reclipsen. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/61501/all/Reclipsen
Vallerand AHA, Sanoski CAC, . Reclipsen [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 September 17]. Available from: https://www.drugguide.com/ddo/view/Davis-Drug-Guide/61501/all/Reclipsen.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Reclipsen
ID - 61501
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://www.drugguide.com/ddo/view/Davis-Drug-Guide/61501/all/Reclipsen
PB - F.A. Davis Company
ET - 19
DB - Davis's Drug Guide
DP - Unbound Medicine
ER -